MetroPlusHealth utilizes clinical review criteria for based upon a review of currently available clinical information (including FDA labeling, clinical outcome studies in the peer-reviewed published medical literature, regulatory status of the technology, evidence-based guidelines of public health and health research agencies, evidence-based guidelines and positions of leading national health professional organizations, and other relevant factors).
MetroPlusHealth expressly reserves the right to revise these conclusions as clinical information changes and welcomes further relevant information. The conclusion that a particular service or supply is medically necessary does not constitute a representation or warranty that this service or supply is covered and/or paid for by MetroPlusHealth, as some programs exclude coverage for services or supplies. If there is a discrepancy between our internal established guidelines and a member’s benefits program, the benefits program will govern. In addition, coverage may be mandated by applicable legal requirements of a state, the Federal Government or the Centers for Medicare & Medicaid Services (CMS) for Medicare and Medicaid members
Click here to View our Provider Pharmacy Policy.
Click here to view billing guidance for Duchenne Muscular Dystrophy Agents.
Practitioner Dispenser Policy
Click here to view billing guidance for Practitioner Dispensing.
2022-2023 Vaccine Administration Network
Click here to view billing guidance for the Vaccine Administration Network.
COVID-19 Pharmacy Updates
COVID-19 At-Home Antigen Test Pharmacy Billing Guide for Medicaid
COVID-19 Oral Antivirals Pharmacy Billing Guide
COVID-19 Specimen Collection and Diagnostic Testing Pharmacy Billing Guide for Medicaid
COVID-19 Vaccine Pharmacy Billing Guide
COVID-19 Monoclonal Antibodies Billing Guidance for Medicaid
COVID-19 Vaccine Counseling Billing Guidance for Medicaid
COVID-19 Therapeutics Locator (arcgis.com)